BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23849306)

  • 1. Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients.
    Sharma S; Joseph J; Chonchol M; Kaufman JS; Cheung AK; Rafeq Z; Smits G; Kendrick J;
    Clin Nephrol; 2013 Nov; 80(5):313-21. PubMed ID: 23849306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
    Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
    Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-23 and cardiac structure and function.
    Agarwal I; Ide N; Ix JH; Kestenbaum B; Lanske B; Schiller NB; Whooley MA; Mukamal KJ
    J Am Heart Assoc; 2014 Feb; 3(1):e000584. PubMed ID: 24525546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
    Gutiérrez OM; Januzzi JL; Isakova T; Laliberte K; Smith K; Collerone G; Sarwar A; Hoffmann U; Coglianese E; Christenson R; Wang TJ; deFilippi C; Wolf M
    Circulation; 2009 May; 119(19):2545-52. PubMed ID: 19414634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction.
    Milani RV; Drazner MH; Lavie CJ; Morin DP; Ventura HO
    Am J Cardiol; 2011 Oct; 108(7):992-6. PubMed ID: 21784383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
    Seiler S; Cremers B; Rebling NM; Hornof F; Jeken J; Kersting S; Steimle C; Ege P; Fehrenz M; Rogacev KS; Scheller B; Böhm M; Fliser D; Heine GH
    Eur Heart J; 2011 Nov; 32(21):2688-96. PubMed ID: 21733911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.
    Almahmoud MF; Soliman EZ; Bertoni AG; Kestenbaum B; Katz R; Lima JAC; Ouyang P; Miller PE; Michos ED; Herrington DM
    J Am Heart Assoc; 2018 Sep; 7(18):e008334. PubMed ID: 30371180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in left ventricular structure and function following renal artery revascularization.
    Corriere MA; Hoyle JR; Craven TE; D'Agostino RB; Edwards MS; Moore PS; Hansen KJ
    Ann Vasc Surg; 2010 Jan; 24(1):80-4. PubMed ID: 19631505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and risk factors for left ventricular disorders in chronic uraemia.
    Parfrey PS; Foley RN; Harnett JD; Kent GM; Murray DC; Barre PE
    Nephrol Dial Transplant; 1996 Jul; 11(7):1277-85. PubMed ID: 8672023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships Between Left Ventricular Structure and Function According to Cardiac MRI and Cardiac Biomarkers in End-Stage Renal Disease.
    Ross BA; Wald R; Goldstein MB; Yuen DA; Leipsic J; Kiaii M; Rathe A; Deva DP; Kirpalani A; Bello OO; Graham JJ; Leong-Poi H; Connelly KA; Yan AT
    Can J Cardiol; 2017 Apr; 33(4):501-507. PubMed ID: 28222921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.
    Lee JA; Kim DH; Yoo SJ; Oh DJ; Yu SH; Kang ET
    Perit Dial Int; 2006; 26(3):360-5. PubMed ID: 16722030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
    Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
    Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-23 and cognitive performance in hemodialysis patients.
    Drew DA; Tighiouart H; Scott TM; Lou KV; Fan L; Shaffi K; Weiner DE; Sarnak MJ
    Hemodial Int; 2014 Jan; 18(1):78-86. PubMed ID: 24164913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular dysfunction after mitral valve repair--the fallacy of "normal" preoperative myocardial function.
    Quintana E; Suri RM; Thalji NM; Daly RC; Dearani JA; Burkhart HM; Li Z; Enriquez-Sarano M; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2752-60. PubMed ID: 25173130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and determinants of left ventricular systolic dyssynchrony in patients with normal ejection fraction received right ventricular apical pacing: a real-time three-dimensional echocardiographic study.
    Fang F; Chan JY; Yip GW; Xie JM; Zhang Q; Fung JW; Lam YY; Yu CM
    Eur J Echocardiogr; 2010 Mar; 11(2):109-18. PubMed ID: 19933290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of fibroblast growth factor 23 in the development of cardiovascular diseases in patients with end-stage renal failure on programmed hemodialysis].
    Dzgoeva FU; Sopoev MY; Bestaeva TL; Khamitsaeva OV; Ktsoeva FA; Sageeva RO
    Ter Arkh; 2016; 88(12):51-56. PubMed ID: 28139560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.